InvAscent
VC Fund
Port Louis, Mauritius
InvAscent is a VC fund in Port Louis focused on Health Care and Manufacturing. InvAscent is the investment advisor to EILSF (Fund I), India Life Sciences Fund II (ILSF-II) and India Life Sciences Fund III (ILSF-III). These funds provide private equity growth capital to companies in the Indian pharmaceutical, healthcare, animal health and medtech industries. Examples of funds usage include capacity expansion, introduction ofnew products, acquisitions, etc. The typical investment size is in the range of USD 10 - 40 million over the life of the investment for a significant minority stake.
- Total investments:
- 28
- Last investment:
- Lead investor:
- 75%
- Fund size:
- $250M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries InvAscent invests in
Stages InvAscent invests in
Countries InvAscent invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $600k–$9.2M
- Private Equity
- $7.4M–$67M
Investment Focus
Industry
- Health Care 16 (57%)
- Manufacturing 12 (43%)
- Pharmaceutical 10 (36%)
- Medical 7 (25%)
- Biotechnology 6 (21%)
Stage
- Private Equity 21 (75%)
- Series A 2 (7%)
- Seed 1 (4%)
- Series B 1 (4%)
- Series C 1 (4%)
Country
- India 24 (86%)
- United States 2 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Hari Buggana
Founder, Chairman and Managing Director
|
Founder, Chairman and Managing Director | Total investments: 2 | Find email | |
T.P. Devarajan
Managing Director
|
Managing Director | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Apex Hospitals offers cardio thoracic vascular surgery, cardiology, critical care, intensive care unit, dermatology, cosmetic, dietetics, nutrition, Ent, gastroenterology, gastrointestinal surgery, general surgery, laparoscopic, bariatric surgery, hematology, audiology, speech therapy, dental, and implant services. An online inquiry form isavailable on the company's website. | Secondary Market / Sep 29, 2025 | ||
| Apex Hospitals offers cardio thoracic vascular surgery, cardiology, critical care, intensive care unit, dermatology, cosmetic, dietetics, nutrition, Ent, gastroenterology, gastrointestinal surgery, general surgery, laparoscopic, bariatric surgery, hematology, audiology, speech therapy, dental, and implant services. An online inquiry form isavailable on the company's website. | $29.9M / Private Equity / Sep 29, 2025 | ||
| SRV Hospital provides plastic surgery, psychiatry, pediatrics and neonatology, orthopedics, oncology, physiotherapy, neurology, nephrology, gynecology and obstetrics, general surgery-laparoscopy, gastroenterology, ent, dietetics, dermatology, pulmonary/respiratory medicine, and cardiology services. | $16.4M / Private Equity / Apr 19, 2025 | ||
| Maiva Pharma is a manufacturer of liquid sterile formulations in small volume glass vials, ampoules, and large volume glass bottles. | $120M / Private Equity / May 02, 2024 | ||
| Fleming Laboratories provides API development and manufacturing facilities. Their services include research and development, manufacturing, infrastructure, and quality management. They respond to customer inquiries by phone and email. | $13.2M / Private Equity / Dec 19, 2023 | ||
| In addition to developing our own software to aid you in transferring images or keeping your records, we also act as consultants and provide valuable services to healthcare administrators and medical professionals. Regardless of the size of your practice or hospital, it's difficult and nearly impossible to do it alone. We make use of thelatest standards and practices to streamline your records and images, as well as develop unique software that further streamlines the acquisition and analysis of information. We also can help you integrate different sets of data, reducing load time and increasing the effectiveness of care. Take a look at some of what we do, and take a chance. | $10M / Private Equity / Dec 18, 2023 | ||
| Pregna International is a contraceptive device manufacturer that specializes in IUDs, hormonal IUDs, and tubal rings. | $15.9M / Private Equity / Jun 21, 2023 | ||
| General Diagnostics International is a responsible laboratory that prioritizes the well-being of its patients. GD uses a combination of emotional devotion and innovation to reduce the cost of diagnostics to a fraction of what it is currently available for, allowing the masses to benefit. | $10.5M / Private Equity / Jun 06, 2023 | ||
| Sunways is a pharmaceutical company, manufacturing and marketing a wide range of formulations in Ophthalmology and ENT. | $14.7M / Private Equity / Nov 25, 2022 | ||
| Accumax is a producer of liquid handling products. | $67.2M / Private Equity / Jun 02, 2022 | ||
| See all 28 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does InvAscent invest in?
InvAscent invests primarily in Health Care, Manufacturing and Pharmaceutical startups, most often at Private Equity and Series A stage. Most of the 28 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is InvAscent's check size?
InvAscent typically joins rounds of $600k–$9.2M at Series A and $7.4M–$67M at Private Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds InvAscent participates in.
How do I contact InvAscent?
Public channels for InvAscent include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at InvAscent?
The team at InvAscent includes Hari Buggana (Founder, Chairman and Managing Director) and T.P. Devarajan (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
